Is a $99 app enough if you stopped losing weight on GLP-1?

You reached the top dose a while ago. The weight came off steadily on the way up, then the scale stopped, and it has stayed stopped. Once a month a telehealth clinician spends about fifteen minutes confirming that you want the refill, and when you asked what comes next, you were told there is nothing else to try. So you have stopped losing weight on GLP-1 medication, you are still paying every month, and a fair question follows: if the refill is all anyone offers, why pay $299 for it when a $99-a-month app will send the same box?

This piece takes that objection seriously, with published prices (every one dated) and the year-one totals for both sides set next to each other. The patient described here is a composite drawn from situations like yours, not a real person. Where the app is the better purchase, the piece says so.

Fifteen minutes, a refill, and a polite dead end

The arrangement made sense when you started. You wanted a GLP-1, the app could prescribe one, and its monthly price was lower than anything else you could find. There was a questionnaire, a short check-in, and a package at the door. For the first stretch it delivered what you paid for: the dose went up on schedule and the weight came down.

Then the dose ran out of room. You are on the highest dose your medication comes in, and the monthly check-ins have settled into a script. Any side effects? Any changes? Do you want to continue? The clinician is whoever is on the schedule that day, and the conversation rarely goes past the refill. Nobody has ordered blood work since you started. Nobody has asked whether your thyroid has been checked, whether a hormonal change might be part of the picture, or what your fasting insulin looked like before the medication and looks like now.

When you raised the plateau, the answer was kind and final. You are on the maximum, and the medication is doing what it can. There is nothing else to try, so keep the refill and check in next month.

That answer leaves you holding a monthly bill and no plan. You are paying to hold your position, and if holding your position is all that is on offer, the rational move is to hold it as cheaply as possible. If the app and the membership are the same thing, the cheaper one wins, and many people in your position reach exactly that conclusion. It is a reasonable one.

The difficulty lies in the phrase "the same thing," which depends on what you believe you are buying. If you are buying a prescription refill, the two are close, and the app costs less. If you are buying an answer to why the refill stopped working, the two prices contain different things, and the only way to see the difference is to open them up.

What the $99 pays for, and what a plateau is asking

Start with the $99 itself. Our guide to the true monthly cost of GLP-1 telehealth uses each company's published self-pay prices as of August 2026. In it, Found advertises a $99-a-month platform fee. The compounded semaglutide or liraglutide is billed on top at $199 a month on a 12-month plan or $299 month to month, which puts the true monthly cost at $298 to $398. The $99 gets you in the door; the medication is most of the bill. Henry Meds, a compounding-only platform, runs $300 to $500 a month at September 2026 published prices, and its year one comes to $3,600 to $6,000 with no labs in the fee. In the August chart, Henry Meds also priced tirzepatide above semaglutide, which matters to anyone whose next step might be a different molecule.

Not every $99 headline is a compounded one, and fairness requires saying so. Sesame's Success program is $99 per 28 days and includes consults, basic labs and messaging, with branded medication bought separately through the manufacturer channel: roughly $448 a month all-in on Wegovy at August 2026 prices. If you are comparing apps, read the medication line before the headline.

What these models share is their purpose. The cost guide calls them weight-loss verticals: they compete on access to a molecule and on the price of delivering it. The fee buys a prescriber, the prescription and a check-in. Inside that design, the monthly visit has one job, which is to decide whether the refill should continue, and fifteen minutes is enough for that job. It was never sized for a harder question.

If your app fills a compounded copy, a second set of facts is worth knowing, stated plainly. Compounded GLP-1 was legal and common during the 2021–2025 FDA shortage. The shortage has resolved, large-scale compounding is now restricted, and the manufacturers have pursued the remaining sellers in court. The FDA's page on unapproved GLP-1 drugs used for weight loss sets out the agency's concerns, including reports about dosing and about added ingredients. None of that means you did anything wrong by using one; patients who did were following the market as it stood. It does mean the top dose you reached is a pharmacy's preparation rather than the FDA-approved branded product, and that the clinician who prescribes is the person whose license carries the responsibility for that choice.

Now the plateau. A refill visit asks one question: continue or stop? A plateau at the top dose asks a different one: why has the scale stopped moving while the dose stays the same? Answering that takes information a questionnaire and a scale cannot provide. The cost guide lists what a weight-only program is not built to look at: the thyroid quietly stalling the protocol, the fasting insulin rising years before glucose moves, the ApoB that stays dangerous after the scale improves, and the hormonal transition driving the weight in the first place. Each of those shows up in blood work or a careful history. None of them shows up on a scale.

Within a model built around one molecule at one price, the statement may well be accurate, because that menu has been exhausted. Whether your own biology has run out of options is a separate question, and no one on a fifteen-minute refill call has the data to answer it.

What $299 changes, what it costs, and what it does not do

The GoodLife Health membership is $299 a month, month to month. The first charge is $598 and covers your first two months. If the clinician cannot accept you into care, the $598 is refunded in full; once you are accepted, the first two months are non-refundable. Medication billed by a pharmacy follows that pharmacy's own return and refund policy.

The fee buys the clinical relationship the refill model leaves out. It covers clinicians licensed in all fifty states, four cardiometabolic lab panels a year, every result in your own hands, asynchronous messaging with the care team, and video visits. It is the same fee whatever medication is indicated and whatever the dose. We call that Medication-Neutral Pricing: no molecule upcharge and no dose upcharge, so if a clinician judges that a different molecule makes sense, your fee does not move.

The order of work is the point of the model: diagnosis first, then treatment, then the long haul. For a patient who has plateaued, that starts with a Biomarker Audit, a comprehensive cardiometabolic panel read by a clinician who can act on what it shows. Depending on the results and your history, the clinician might keep your current medication with evidence behind the decision, move you to a different branded GLP-1 (Wegovy, Zepbound, Mounjaro or Ozempic), or address thyroid or hormone findings where treatment is indicated. Any FDA-approved medication a clinician judges indicated can be prescribed to the pharmacy you choose. The clinician decides, and nothing in the membership promises a particular prescription or a particular result. The labs repeat every quarter, so whatever is tried gets checked against data instead of a monthly yes or no.

Medication is billed separately, and here the comparison turns honest in the other direction. GoodLife Health prescribes branded, FDA-approved medication only, to the pharmacy you choose, at that pharmacy's own price. GoodLife Health sets nothing, sees nothing and takes nothing on medication. As published by the manufacturers in September 2026, NovoCare lists Wegovy pens at $199 a month for the first two fills (an introductory offer for new patients through December 2026) and $349 a month after that, with the Wegovy pill from $149 a month at lower doses. LillyDirect lists Zepbound vials at $299 to $449 a month depending on dose. A patient already at the top of the dose range should plan around the upper figures. At those prices, our guide to the real ROI of a $299/month health membership puts the all-in cost for a member on a branded GLP-1 at roughly $498 to $748 a month.

If you are moving from a compounded product, your medication line will rise, and it would be dishonest to suggest otherwise. Whether insurance covers a branded GLP-1 for you is between you, your plan and your pharmacy. Prior authorization is the pharmacy's process; GoodLife Health does not run it, speed it or promise its outcome. The membership replaces the primary-care relationship and pairs with your insurance for catastrophic coverage; it does not replace insurance. The membership fee is generally eligible for HSA or FSA pre-tax dollars.

Read the table the way you would read your own bank statement. Once branded medication is added, the membership's year one is likely to come out above the app's range, and this page does not pretend otherwise. The extra pays for four lab panels, a clinician with room to treat more than weight, branded medication from a pharmacy you choose, and a fee that stays the same if the plan changes.

There are also limits to state as clearly as the prices. The membership does not guarantee weight loss, a typical result, or that your plateau will break. It does not prescribe compounded GLP-1 under any circumstance, so if a compounded product at a compounded price is what you want, this is the wrong place to look. It does not promise that any medication will be covered. Not everyone is accepted: the path is the eligibility check, the intake, the checkout, then a clinician's review.

So, is the $99 app the same thing?

For the refill, close enough. Both can put a GLP-1 in your hands each month, and the app does it for less. If your medication were still working and your labs were not a question, that would settle it, and the $99 app would be the sensible purchase.

You are in a different position. You are on the top dose, the scale has stopped, and the clinician you pay has told you there is nothing more on offer. Paying less for the same dead end does save money, but it leaves the question of why you stopped unanswered, along with whether something in your thyroid, insulin, lipids or hormones is part of the answer. The membership is built for that question: find out what is going on first, then treat, then keep checking every quarter. It costs more, and the bill says so. It cannot guarantee the outcome you want. What it gives the question is a clinician, a panel of data and the room to act on both.

The ROI guide prices every alternative a patient like you realistically considers, including concierge medicine at the far end of the range. GoodLife Health sits between the full concierge practice and the $99-a-month compounded app, on purpose. If you want the cheapest refill, the app is cheaper. If you want someone to look, the membership is what that costs.

Who this is not for

If your GLP-1 is still working, your app's price suits you, and you have no questions about your labs, keep the app. The membership would cost you more for care you do not currently need, and saying so is the honest answer. The same goes for anyone set on compounded GLP-1: GoodLife Health does not prescribe it, and the decision about what you take is yours. If you want a guarantee that the plateau will break, or a promise of any weight-loss number, no responsible clinician can give one, and we will not. If you are a healthy adult who sees a doctor twice a year and takes no medication, you will not recoup $3,588, and you should not buy this. And if you are hoping a membership can stand in for insurance, it cannot; it pairs with insurance.

Related Reading

• The True Monthly Cost of GLP-1 Telehealth: An Honest Comparison
• The Real ROI of a $299/Month Health Membership: Every Alternative, Priced Honestly

References

1. NovoCare Pharmacy — Wegovy self-pay pricing (Novo Nordisk). 2026. www.novocare.com/pharmacy/wegovy.html
2. Zepbound Self Pay Journey Program — LillyDirect vial pricing (Eli Lilly). 2026. zepbound.lilly.com/savings
3. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration). 2025. www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss